Anaphase Promoting Complex Antibodies

Santa Cruz Biotechnology features a diverse variety of Anaphase Promoting Complex Antibodies for research in cell cycle regulation and mitosis. Anaphase Promoting Complex Antibodies are compatible with multiple techniques, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). The anaphase promoting complex (APC) plays a critical role in the regulation of the cell cycle by targeting specific proteins for degradation, thereby ensuring proper chromosome segregation during cell division. Dysregulation of the APC can lead to various diseases, including cancer, making it a significant focus of research in understanding tumorigenesis and potential therapeutic interventions. Understanding APC function is essential for developing new approaches to cancer treatment and prevention. Researchers studying APC can explore its role in chromosome segregation, cell cycle progression, and protein degradation pathways. Current investigations focus on how APC dysregulation contributes to genomic instability and cancer development. Ongoing research examines the complex interactions between APC and its substrate proteins during different phases of the cell cycle. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to advance their understanding of cell cycle regulation and its impact on human health.